During the past decade, James Graham Brown Cancer Center conducted 108 clinical trials. In the 10-year time frame, 108 clinical trials started and 83 clinical trials were completed, i.e. on average, 76.9% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 37 clinical trials were completed. i.e. 105.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "James Graham Brown Cancer Center" #1 sponsor was "Radiation Therapy Oncology Group" with 51 trials, followed by "National Cancer Institute (NCI)" with 46 trials sponsored, "University of Louisville" with 36 trials sponsored, "Alliance for Clinical Trials in Oncology" with 16 trials sponsored and "SWOG Cancer Research Network" with 16 trials sponsored. Other sponsors include 145 different institutions and companies that sponsored additional 89 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "James Graham Brown Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 104 trials as a collaborator, "James Graham Brown Cancer Center" with 37 trials as a collaborator, "NRG Oncology" with 37 trials as a collaborator, "SWOG Cancer Research Network" with 9 trials as a collaborator and "North Central Cancer Treatment Group" with 7 trials as a collaborator. Other collaborators include 79 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "James Graham Brown Cancer Center" are "Head and Neck Cancer" (22 trials), "Breast Cancer" (20 trials), "Lung Cancer" (16 trials), "Melanoma" (13 trials) and "Prostate Cancer" (12 trials). Many other conditions were trialed in "James Graham Brown Cancer Center" in a lesser frequency.

Most popular intervention types in "James Graham Brown Cancer Center" are "Drug" (227 trials), "Radiation" (102 trials), "Biological" (77 trials), "Other" (71 trials) and "Procedure" (59 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (35 trials), "Laboratory Biomarker Analysis" (33 trials), "Quality-of-Life Assessment" (27 trials), "Placebo" (22 trials) and "Cisplatin" (20 trials). Other intervention names were less common.

The vast majority of trials in "James Graham Brown Cancer Center" are 240 trials for "All" genders, 53 trials for "Female" genders and 15 trials for "Male" genders.

Currently, there are NaN active trials in "James Graham Brown Cancer Center". undefined are not yet recruiting, 42 are recruiting, 69 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 139 completed trials in James Graham Brown Cancer Center, 2 suspended trials, and 35 terminated clinical trials to date.

Out of the total trials that were conducted in James Graham Brown Cancer Center, 43 "Phase 1" clinical trials were conducted, 128 "Phase 2" clinical trials and 137 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 15 trials that are defined as “Not Applicable".